Research Article
Design of an Implantable Device for Ocular Drug Delivery
Table 1
Diffusion coefficient of drugs for the AMD.
| Drug | Drug name (type) | Diffusion coefficient (cm2/s) | Average dosage (nL/min) | Injection amount/periods | References |
|
Antiangiogenic | Macugen (pegaptanib sodium) | | 0.2083 | 3 mg/10 days | Swanson [12] | Lucentis (ranibizumab) | | 0.0124 | 0.5 mg/month |
Molokhia et al. [13] | Intravitrea Avastin (bevacizumab) | | 0.0289 | 1.25 mg/month | |
| Synthetic corticosteroid | Fluocinolone | |
0.0744 |
15 mg/20 weeks | Li et al. and Jaffe et al. [14, 15] | Acetonide | | | |
|
|